Isorhapontigenin (ISO) inhibits invasive bladder cancer formation In Vivo and human bladder cancer invasion In Vitro by targeting STAT1/FOXO1 axis

Guosong Jiang, Amy D. Wu, Chao Huang, Jiayan Gu, Liping Zhang, Haishan Huang, Xin Liao, Jingxia Li, Dongyun Zhang, Xingruo Zeng, Honglei Jin, Haojie Huang, Chuanshu Huang

Research output: Contribution to journalArticlepeer-review

37 Scopus citations


Although our most recent studies have identified Isorhapontigenin (ISO), a novel derivative of stilbene that isolated from a Chinese herb Gnetum cleistostachyum, for its inhibition of human bladder cancer growth, nothing is known whether ISO possesses an inhibitory effect on bladder cancer invasion. Thus, we addressed this important question in current study and discovered that ISO treatment could inhibit mouse-invasive bladder cancer development following bladder carcinogen N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) exposure in vivo. We also found that ISO suppressed human bladder cancer cell invasion accompanied by upregulation of the forkhead box class O 1 (FOXO1) mRNA transcription in vitro. Accordingly, FOXO1 was profoundly downregulated in human bladder cancer tissues and was negatively correlated with bladder cancer invasion. Forced expression of FOXO1 specifically suppressed high-grade human bladder cancer cell invasion, whereas knockdown of FOXO1 promoted noninvasive bladder cancer cells becoming invasive bladder cancer cells. Moreover, knockout of FOXO1 significantly increased bladder cancer cell invasion and abolished the ISO inhibition of invasion in human bladder cancer cells. Further studies showed that the inhibition of Signal transducer and activator of transcription 1 (STAT1) phosphorylation at Tyr701 was crucial for ISO upregulation of FOXO1 transcription. Furthermore, this study revealed that metalloproteinase-2 (MMP-2) was a FOXO1 downstream effector, which was also supported by data obtained from mouse model of ISO inhibition BBN-induced mouse-invasive bladder cancer formation. These findings not only provide a novel insight into the understanding of mechanism of bladder cancer's propensity to invasion, but also identify a new role and mechanisms underlying the natural compound ISO that specifically suppresses such bladder cancer invasion through targeting the STAT1-FOXO1-MMP-2 axis.

Original languageEnglish (US)
Pages (from-to)567-580
Number of pages14
JournalCancer Prevention Research
Issue number7
StatePublished - Jul 2016

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Isorhapontigenin (ISO) inhibits invasive bladder cancer formation In Vivo and human bladder cancer invasion In Vitro by targeting STAT1/FOXO1 axis'. Together they form a unique fingerprint.

Cite this